Gainers

• Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million.
• Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved upwards by 10.29% to $0.73. The market value of their outstanding shares is at $14.1 million.
• Adicet Bio (NASDAQ:ACET) shares increased by 9.82% to $9.91. The market value of their outstanding shares is at $77.4 million.
• Adagio Medical Holdings (NASDAQ:ADGM) stock rose 6.15% to $0.21. The company's market cap stands at $4.6 million.
• SILO Pharma (NASDAQ:SILO) shares moved upwards by 5.74% to $1.84. The company's market cap stands at $3.0 million.
• PharmaCyte Biotech (NASDAQ:PMCB) stock moved upwards by 5.44% to $0.47. The market value of their outstanding shares is at $4.8 million.

Losers

• NewGenIvf Group (NASDAQ:NIVF) stock declined by 7.7% to $0.52 during Friday's after-market session. The company's market cap stands at $1.3 million.
• 20/20 Biolabs (NASDAQ:AIDX) shares declined by 5.46% to $0.41. The market value of their outstanding shares is at $5.4 million.
• Gossamer Bio (NASDAQ:GOSS) stock fell 5.31% to $10.36. The market value of their outstanding shares is at $66.8 million.
• Silexion Therapeutics (NASDAQ:SLXN) stock fell 5.27% to $0.25. The market value of their outstanding shares is at $1.4 million.
• HCW Biologics (NASDAQ:HCWB) shares fell 5.19% to $1.83. The market value of their outstanding shares is at $3.6 million.
• FibroBiologics (NASDAQ:FBLG) stock decreased by 5.04% to $1.32. The market value of their outstanding shares is at $9.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.